ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 97 filers reported holding ONCOCYTE CORP in Q3 2021. The put-call ratio across all filers is 0.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $19,751 | +6979.2% | 61,548 | -83.9% | 0.00% | – |
| Q3 2022 | $279 | -42.7% | 381,532 | -29.6% | 0.00% | – |
| Q2 2022 | $487 | -99.9% | 541,983 | +17.8% | 0.00% | – |
| Q1 2022 | $686,000 | -27.3% | 460,004 | +5.7% | 0.00% | – |
| Q4 2021 | $944,000 | -36.5% | 435,040 | +4.2% | 0.00% | – |
| Q3 2021 | $1,487,000 | -32.5% | 417,515 | +8.8% | 0.00% | – |
| Q2 2021 | $2,203,000 | +151.5% | 383,853 | +127.4% | 0.00% | – |
| Q1 2021 | $876,000 | +136.8% | 168,779 | +9.0% | 0.00% | – |
| Q4 2020 | $370,000 | +53.5% | 154,778 | -10.8% | 0.00% | – |
| Q3 2020 | $241,000 | +301.7% | 173,427 | +452.9% | 0.00% | – |
| Q2 2020 | $60,000 | +27.7% | 31,367 | +63.4% | 0.00% | – |
| Q1 2020 | $47,000 | 0.0% | 19,193 | +3.9% | 0.00% | – |
| Q2 2018 | $47,000 | -23.0% | 18,466 | -36.8% | 0.00% | – |
| Q1 2018 | $61,000 | -72.0% | 29,217 | -30.5% | 0.00% | – |
| Q2 2017 | $218,000 | -0.5% | 42,015 | +14.3% | 0.00% | – |
| Q1 2017 | $219,000 | +108.6% | 36,750 | +24.3% | 0.00% | – |
| Q2 2016 | $105,000 | -21.6% | 29,558 | +1.3% | 0.00% | – |
| Q1 2016 | $134,000 | – | 29,165 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 3,596,680 | $16,725,000 | 2.33% |
| Artal Group S.A. | 150,000 | $698,000 | 0.01% |
| Destination Wealth Management | 29,656 | $138,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 145,000 | $674,000 | 0.01% |
| IHT Wealth Management, LLC | 563 | $2,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 695 | $3,000 | 0.00% |
| NORTHERN TRUST CORP | 44,048 | $205,000 | 0.00% |
| Vantage Investment Advisors, LLC | 25 | $0 | 0.00% |
| UBS Group AG | 5,204 | $24,000 | 0.00% |
| Legal & General Group Plc | 384 | $2,000 | 0.00% |